Evidence map›Paper›PMID 36371522›Full record

ArticleScientific reports2022

Design of a multi-epitope protein as a subunit vaccine against lumpy skin disease using an immunoinformatics approach.

Prajna Parimita Kar, Prasanna Babu Araveti, Akshay Kuriakose, Anand Srivastava

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A Genome-Wide Screening of Novel Immunogenic TrLSDV103 Protein of Lumpy Skin Disease Virus and Its Application for DIVA.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. In silico analysis of virulence factors ofIn silico pharmacology · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Prajna Parimita KarNational Institute of Animal Biotechnology (NIAB), Gachibowli, Gopanpalli, Hyderabad, 500 032, Telangana, India.
Prasanna Babu AravetiNational Institute of Animal Biotechnology (NIAB), Gachibowli, Gopanpalli, Hyderabad, 500 032, Telangana, India.
Akshay KuriakoseNational Institute of Animal Biotechnology (NIAB), Gachibowli, Gopanpalli, Hyderabad, 500 032, Telangana, India.
Anand SrivastavaNational Institute of Animal Biotechnology (NIAB), Gachibowli, Gopanpalli, Hyderabad, 500 032, Telangana, India. anand@niab.org.in.
National Institute of Animal Biotechnology · INRegional Centre for Biotechnology · IN

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR17590/GET/119/271/2018Department of Science and Technology, Ministry of Science and Technology, India IF160249Department of Science and Technology, Ministry of Science and Technology, India IF160609
6 · The paper itself

Abstract

Lumpy skin disease (LSD) is a transboundary viral disease of cattle that causes substantial economic loss globally. There is no specific treatment and subunit vaccine for this disease to date. Reports of the global spread of this disease are worrisome. We designed a multi-epitope protein using an immunoinformatics approach in this study. We analyzed the proteome of LSDV and found 32 structural/surface proteins. Four of these 32 proteins were predicted as antigenic and non-homologous to bovine and highly conserved in 26 LSDV isolates. The predicted B-cell epitopes and CTL epitopes were stitched together with the help of an AAY linker leading to the formation of a multi-epitope protein. The in silico study revealed that the modeled subunit vaccine candidate and TLR4 receptor interact with high affinity. This interaction was also found to be stable using a molecular dynamics simulation study. Our study demonstrates a leap towards developing a subunit vaccine against LSD.

Indexed as

Epitopes, T-LymphocyteLumpy Skin DiseaseAnimalsCattleComputational BiologyEpitopes, B-LymphocyteMolecular Docking SimulationVaccines, SubunitEpitopes, B-LymphocyteEpitopes, T-LymphocyteVaccines, Subunit

Identifiers

PMID36371522
PMCPMC9653426
OpenAlexW4309076306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.